What are the opening hours?

Monday 8am - 6pm Tuesday 8am - 6pm Wednesday 8am - 6pm Thursday 8am - 6pm Friday 8am - 6pm

bioMérieux USA

Name: bioMérieux USA
Address: 515 Colorow Drive, Salt Lake City, UT, 84108, US
Telephone: +18017366354

Call Directions Website Contact the business

We set the standard for syndromic infectious disease diagnostics in the US. (Formerly BioFire Diagnostics)

Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place.

11/09/2026

Behind every blood culture bottle is a process most people never see.

Before a BACT/ALERT® blood culture bottle reaches a laboratory, it moves through carefully controlled steps designed to support quality, consistency, and clinical confidence.

See a glimpse of what happens along the way, from manufacturing and quality checks to the people who bring skilled oversight to the process.

Watch the full “We Act For A Positive Impact” video and learn more about the BACT/ALERT® VIRTUO® system from the link in the comments.

11/06/2026

LIVE WEBINAR | November 12 at 1:00 PM ET.

Acute kidney injury (AKI) remains a significant clinical challenge, making early risk assessment critical to supporting timely intervention and patient care.

Join us for a webinar exploring the science behind VIDAS® NEPHROCHECK® [TIMP-2 · IGFBP-7] and the role of the kidney stress biomarkers TIMP-2 and IGFBP-7 in assessing patients at risk for AKI.

Attendees will learn how VIDAS NEPHROCHECK aligns with guideline-based care, can support critical care decision-making, and can be integrated into clinical workflows. We will also discuss real-world implementation strategies and the potential impact on patient care and quality metrics.

Learning objectives include:
• Describe the clinical burden and impact of AKI across patient populations.
• Explain the role of cellular stress biomarkers in early AKI risk assessment.
• Interpret VIDAS NEPHROCHECK results in the context of clinical assessment and patient management.
• Understand how AKI risk assessment can support timely intervention and patient care pathways.

Can’t make it live? Register to receive the recording. Link in the comments.

11/05/2026

An instrument installation is only the beginning of the relationship.

Labs depend on consistent performance, responsive service, and practical guidance when challenges arise. When support is difficult to access, disruption extends beyond the bench.

The BACT/ALERT® VIRTUO® platform is supported by a dedicated service team, including a U.S.-based service organization and technical call center. From training and Lab Optimization Consultancy to maintenance and technical support recognized by the 2025 IMV ServiceTrak™ Clinical Laboratory Awards, the focus is keeping laboratories operational.

In a diagnostics market that continues to shift, service infrastructure and long-term partnership carry real weight.

11/04/2026

WEBINAR | November 10 at 12:00 PM ET

Vaginitis symptoms can overlap, making it difficult to distinguish among common causes using symptoms, physical examination, or traditional office-based methods alone.

Join Amanda Suchanek, PhD, of bioMérieux Medical Affairs for a 30-minute webinar exploring the evolving vaginitis diagnostic landscape. She’ll discuss the roles and limitations of traditional testing, central laboratory testing, and emerging molecular point-of-care approaches.

The session will also examine how the timing of diagnostic results may influence treatment selection, persistent symptoms, patient follow-up, and antimicrobial stewardship.

As part of this evolving landscape, the FDA-cleared and CLIA-waived BIOFIRE® SPOTFIRE® Vaginitis (VG) Panel is designed to support informed clinical decision making at the point of care, delivering eight clinically relevant results in approximately 20 minutes.

Register to join the webinar here: https://bit.ly/4yQ2JAc

11/02/2026

WEBINAR | November 11 at 1:00 PM ET

Modern antimicrobial stewardship depends on more than generating laboratory data. The value comes from turning that information into insights teams can use.

In the next episode of AMR Pathways, Heinz Salazar, MBA-HCM, MLS, Microbiology Manager at Tampa General Hospital, will explore how laboratory data, connectivity, dashboards, and analytics can support laboratory efficiency, clinical decision making, and stewardship initiatives.

The discussion will also look at opportunities for collaboration across the laboratory, stewardship teams, IT leaders, and clinicians to build a more integrated, data-driven stewardship ecosystem.

Register to join us on November 11. Link in the comments.

10/29/2026

Last week, we announced the FDA clearance and CLIA waiver of the BIOFIRE® SPOTFIRE® Vaginitis (VG) Panel. This week, we're continuing the conversation about why this milestone matters for women's health.

Vaginitis affects millions of women each year, yet diagnosis isn't always straightforward. Symptoms of bacterial vaginosis, candidiasis, and trichomoniasis often overlap, making it difficult to identify the underlying cause based on symptoms alone.

This uncertainty matters. Different causes can require different treatment approaches, and an unclear diagnosis may delay appropriate care.
Having molecular test results available while the patient is still present may help clinicians make more informed treatment decisions and could give patients greater clarity about their next steps.

The BIOFIRE SPOTFIRE VG Panel is designed to support this process, delivering eight clinically relevant results in about 20 minutes.

Learn more about the panel via the link in the comments.

10/28/2026

Timely diagnostic information may help support treatment decisions when septic arthritis is suspected.

In a multicenter study of 475 adults across nine U.S. emergency departments, researchers evaluated synovial fluid PCR testing and found high concordance with synovial fluid culture. The findings also suggested PCR may help reduce antimicrobial treatment delays and may increase pathogen detection when culture yield is affected by antibiotic pretreatment.

The study evaluated the BIOFIRE® Joint Infection (JI) Panel in patients with suspected septic arthritis.

Read the full study for the findings and potential clinical utility of using PCR testing in conjunction with culture. Link in comments.

10/27/2026

WEBINAR | November 3 at 1:00 PM ET

Diagnosing tropical fever pathogens can present challenges in both endemic and non-endemic settings.

The final Diseases Without Borders webinar explores how delayed or incomplete diagnoses can affect patient outcomes, surveillance efforts, and public health decision-making. The discussion will also examine lessons from public health, clinical, military, and research environments that may inform preparedness and global health security.

The session will conclude with a Q&A featuring speakers from all three episodes, including a selection of questions submitted during Episodes 1 and 2.

Register to join us here: https://bit.ly/4z0zbQ2

10/24/2026

WEBINAR | October 27 at 1:00 PM ET

For patients returning from travel with fever, the underlying cause may not always be straightforward.

The second Diseases Without Borders webinar explores how the BIOFIRE® FILMARRAY® Tropical Fever (TF) Panel can help uncover atypical etiologies and co-infections that may impact diagnosis and treatment decisions. This discussion will also explore how a faster, more comprehensive diagnostic test may impact laboratory workflows and patient management.

Have a question during the webinar? Submit it through the Q&A feature for a chance to have it addressed during the final episode on November 3.

Register to join us here: https://bit.ly/4z0zbQ2

10/23/2026

IDWeek is celebrating 15 years. We’re marking a milestone of our own.

Ten years ago, the BIOFIRE® FILMARRAY® TORCH System helped shape a new era of syndromic testing. A decade later, the work continues as testing moves into new settings and new areas of clinical need.

At IDWeek 2026, we’re sharing what we’ve learned and where we’re headed next, from syndromic testing and fast ID/AST to informatics, women’s health, and other emerging diagnostic needs.

Come see us at booth 825 through October 24.
See what we’re bringing to IDWeek. Link in comments.

Address

515 Colorow Drive
Salt Lake City, UT
84108

Opening Hours

Monday	8am - 6pm
Tuesday	8am - 6pm
Wednesday	8am - 6pm
Thursday	8am - 6pm
Friday	8am - 6pm

Telephone

+18017366354

Website

https://www.biomerieux.com/

Alerts

Be the first to know and let us send you an email when bioMérieux USA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.